INTERNATIONAL PATENT: OM PHARMA SA FILES APPLICATION FOR "SMALL MOLECULE TARGETING TLR4 OVEREXPRESSING TUMORS AND ASSOCIATED IMMUNOSUPPRESSIVE, ANGIOGENIC AND FIBROTIC COMPLICATIONS"

GENEVA, March 2 -- OM PHARMA SA (Rue du Bois-du-Lan, 221217 Meyrin) filed a patent application (PCT/EP2025/073654) for "SMALL MOLECULE TARGETING TLR4 OVEREXPRESSING TUMORS AND ASSOCIATED IMMUNOSUPPRESSIVE, ANGIOGENIC AND FIBROTIC COMPLICATIONS" on Aug 19, 2025. With publication no. WO/2026/041647, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BAUER, Jacques (Chemin de la Moraine 311162 Saint-Prex), SELLAM, Zaki (Robinienweg 214153 Reinach)

Abstract: The present disclosure relates to the use of compound (I) and any of i...